140 related articles for article (PubMed ID: 32516630)
1. The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension.
Palma JA; Redel-Traub G; Porciuncula A; Samaniego-Toro D; Millar Vernetti P; Lui YW; Norcliffe-Kaufmann L; Kaufmann H
Parkinsonism Relat Disord; 2020 Jun; 75():97-104. PubMed ID: 32516630
[TBL] [Abstract][Full Text] [Related]
2. Management Strategies for Comorbid Supine Hypertension in Patients with Neurogenic Orthostatic Hypotension.
Isaacson SH; Dashtipour K; Mehdirad AA; Peltier AC
Curr Neurol Neurosci Rep; 2021 Mar; 21(4):18. PubMed ID: 33687577
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the changes in supine blood pressure with long-term use of droxidopa in patients with neurogenic orthostatic hypotension.
Hewitt LA; Lindsten A; Gorny S; Karnik-Henry M; Kymes S; Favit A
Health Sci Rep; 2021 Mar; 4(1):e227. PubMed ID: 33521332
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal prevalence of neurogenic orthostatic hypotension in the idiopathic Parkinson Progression Marker Initiative (PPMI) cohort.
Beach P; McKay JL
Auton Neurosci; 2024 Jun; 253():103173. PubMed ID: 38692034
[TBL] [Abstract][Full Text] [Related]
5. Association of Supine Hypertension Versus Standing Hypotension With Adverse Events Among Middle-Aged Adults.
Earle WB; Kondo JK; Kendrick KN; Turkson-Ocran RA; Ngo L; Cluett JL; Mukamal KJ; Daya Malek N; Selvin E; Lutsey PL; Coresh J; Juraschek SP
Hypertension; 2023 Nov; 80(11):2437-2446. PubMed ID: 37646155
[TBL] [Abstract][Full Text] [Related]
6. Neurogenic Orthostatic Hypotension in Parkinson Disease: A Primer.
Cutsforth-Gregory JK; Low PA
Neurol Ther; 2019 Dec; 8(2):307-324. PubMed ID: 31456212
[TBL] [Abstract][Full Text] [Related]
7. Synchronous monitoring of brain-heart electrophysiology using heart rate variability coupled with rapid quantitative electroencephalography in orthostatic hypotension patients with α-synucleinopathies: Rapid prediction of orthostatic hypotension and preliminary exploration of brain stimulation therapy.
Lin L; Cheng Y; Huang P; Zhang J; Zheng J; Pan X
CNS Neurosci Ther; 2024 Feb; 30(2):e14571. PubMed ID: 38421092
[TBL] [Abstract][Full Text] [Related]
8. Orthostatic heart rate changes in patients with autonomic failure caused by neurodegenerative synucleinopathies.
Norcliffe-Kaufmann L; Kaufmann H; Palma JA; Shibao CA; Biaggioni I; Peltier AC; Singer W; Low PA; Goldstein DS; Gibbons CH; Freeman R; Robertson D;
Ann Neurol; 2018 Mar; 83(3):522-531. PubMed ID: 29405350
[TBL] [Abstract][Full Text] [Related]
9. Brain white matter changes and their associations with non-motor dysfunction in orthostatic hypotension in α-synucleinopathy: A NODDI study.
Lin L; Huang P; Cheng Y; Jiang S; Zhang J; Li M; Zheng J; Pan X; Wang Y
CNS Neurosci Ther; 2024 Apr; 30(4):e14712. PubMed ID: 38615364
[TBL] [Abstract][Full Text] [Related]
10. Orthostatic Hypotension in Multiple System Atrophy: Related Factors and Disease Prognosis.
Jiang Q; Zhang L; Lin J; Wei Q; Li C; Hou Y; Ou R; Liu K; Yang T; Xiao Y; Zhao B; Wu Y; Shang H
J Parkinsons Dis; 2023; 13(8):1313-1320. PubMed ID: 38143372
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology, Diagnosis, and Management of Neurogenic Orthostatic Hypotension.
Palma JA; Kaufmann H
Mov Disord Clin Pract; 2017; 4(3):298-308. PubMed ID: 28713844
[TBL] [Abstract][Full Text] [Related]
12. Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.
Palma JA; Kaufmann H
Mov Disord; 2018 Mar; 33(3):372-390. PubMed ID: 29508455
[TBL] [Abstract][Full Text] [Related]
13. Recent updates in autonomic research: orthostatic hypotension in prodromal synucleinopathy; longitudinal morbidity and mortality in orthostatic hypotension with and without supine hypertension; a cardiac vagal sensory system underlying reflex syncope.
Beach P; Lenka A
Clin Auton Res; 2024 Feb; 34(1):13-15. PubMed ID: 38281268
[No Abstract] [Full Text] [Related]
14. Hypotensive episodes at 24-h ambulatory blood pressure monitoring predict adverse outcomes in Parkinson's disease.
Vallelonga F; Valente M; Tangari MM; Covolo A; Milazzo V; Di Stefano C; Sobrero G; Giudici M; Milan A; Veglio F; Lopiano L; Maule S; Romagnolo A
Clin Auton Res; 2024 Apr; 34(2):281-291. PubMed ID: 38662269
[TBL] [Abstract][Full Text] [Related]
15. Determinants of orthostatic hypotension in type 2 diabetes: is cardiac autonomic neuropathy the main factor?
D'Ippolito I; Carlucci MA; D'Amato C; Lauro D; Spallone V
Endocr Pract; 2024 Jun; ():. PubMed ID: 38908717
[TBL] [Abstract][Full Text] [Related]
16. Hypotensive episodes at 24-h Ambulatory Blood Pressure Monitoring predict adverse outcomes in Parkinson's Disease.
Vallelonga F; Valente M; Tangari MM; Covolo A; Milazzo V; Di Stefano C; Sobrero G; Giudici M; Milan A; Veglio F; Lopiano L; Maule S; Romagnolo A
Res Sq; 2024 Feb; ():. PubMed ID: 38405860
[TBL] [Abstract][Full Text] [Related]
17. White Matter Hyperintensities in the Synucleinopathies: Orthostatic Hypotension, Supine Hypertension, or Both?
Kaufmann H; Palma JA
Mov Disord Clin Pract; 2020 Aug; 7(6):595-598. PubMed ID: 32775503
[No Abstract] [Full Text] [Related]
18. Intra-neuronal alpha-synuclein deposition is related to cardiac noradrenergic deficiency and olfactory dysfunction in neurogenic orthostatic hypotension.
Isonaka R; Sullivan P; Holmes C; Goldstein DS
Res Sq; 2024 Mar; ():. PubMed ID: 38529504
[TBL] [Abstract][Full Text] [Related]
19. A pathophysiological biomarker combination separates Lewy body from non-Lewy body neurogenic orthostatic hypotension .
Isonaka R; Sullivan P; Holmes C; Goldstein DS
Clin Auton Res; 2024 Jun; ():. PubMed ID: 38844644
[TBL] [Abstract][Full Text] [Related]
20. Management of Orthostatic Hypotension in Parkinson's Disease.
Fanciulli A; Leys F; Falup-Pecurariu C; Thijs R; Wenning GK
J Parkinsons Dis; 2020; 10(s1):S57-S64. PubMed ID: 32716319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
